That prodded Amgen stock into a breakout. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Keith Speights (TMFFishBiz) Jul 1, 2020 at 3:30PM Author Bio. Amgen stock looks poised for the long haul. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, Disney (NYSE:DIS) Shuts Down Annual Pass Program, But Still Consider Disney a Buy, Surprising Results Prove Little Help to PNC Financial (NYSE:PNC), Progress Software (NASDAQ:PRGS) Slips After Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 10 Blue-Chip “Dogs of the Dow” for 2021, with 4.1% Dividends, Man Who Predicted March 2020 Crash Makes Bold Tech Stock Prediction, Amgen (NASDAQ:AMGN) Given "Neutral" Rating at Royal Bank of Canada, Amgen (NASDAQ:AMGN) Now Covered by Analysts at Daiwa Capital Markets, Oppenheimer Lowers Amgen (NASDAQ:AMGN) Price Target to $274.00, Amgen (NASDAQ:AMGN) Proves the Value of Diversification, BMO Capital Markets Cuts Amgen (NASDAQ:AMGN) Price Target to $304.00, Amgen (NASDAQ:AMGN) Earns Hold Rating from William Blair, Out With The Old, In With The New For The Dow Jones (AMGN), Amgen (NASDAQ:AMGN) Lowered to Strong Sell at BidaskClub, Amgen (NASDAQ:AMGN) Stock Rating Lowered by BidaskClub, Amgen investing in Durham health data firm studying COVID-19 | Raleigh News & Observer, Welcome to the Roaring ’20s, but Maybe Not for Stocks, CORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed deal - Yahoo Finance, CORRECTED-Health data firm Target RWE buys NoviSci in Amgen-backed deal, Amgen Inc. (NASDAQ:AMGN) Director Ronald D. Sugar Sells 1,000 Shares, Health data firm Target RWE buys NoviSci in Amgen-backed deal - Reuters, Amgen and EVOQ Therapeutics ink development deal for autoimmune disorders, EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen - PRNewswire, Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020 - PRNewswire, Gilead, Biogen Lead Biotechs That ‘Need to Do Deals’ for Growth. Start Your Risk-Free Trial Subscription Here, Nestlé recalls 762,000 pounds of pepperoni Hot Pockets, The Latest: Spain confident of vaccine program despite delay, The Latest: Germany reaches more than 1 million vaccinations, The Latest: Brazil 2nd in global deaths; no vaccines yet, GM to build electric delivery vans in Canada, Deaths, self-immolation draw scrutiny on China tech giants, Extremists exploit a loophole in social moderation: Podcasts, 3 Recession-Proof Dividend Stocks to Buy Now. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. The company provided earnings per share (EPS) guidance of $13.25-14.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.09. Learn everything you need to know about successful options trading with this three-part video course. Surprisingly, only roughly 10% of people in the U.S. have made this move... yet it’s already created tens of thousands of millionaires. Omecamtiv mecarbil, an investigational selective cardiac myosin activator, was studied in GALACTIC … View real-time stock prices and stock quotes for a full financial overview. And with Biden and company about to occupy the White House, this could prove to be the #1 most important financial step you take between now and January 20th. The company issued revenue guidance of $22.0-22.9 billion, compared to the consensus revenue estimate of $22.84 billion.Amgen also updated its FY 2019 guidance to $13.25-14.30 EPS. Amgen, Inc. went public on June 17, 1983, for $18 per share.Since its initial public offering (IPO), the stock has split five times. Learn more. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 SmartAsset's free quiz matches you with fiduciary financial advisors in your area in 5 minutes. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Nosotros y nuestros socios almacenaremos y/o accederemos a la información de tu dispositivo mediante el uso de cookies y tecnologías similares, a fin de mostrar anuncios y contenido personalizados, evaluar anuncios y contenido, obtener datos sobre la audiencia y desarrollar el producto. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. This seems, so far, a somewhat rough trend trading session today. Tech Stocks to drop 92%?? Press Releases; Events Calendar; Presentations; Annual Meeting; Stock. Stock Amgen Inc. Summary; Performance; Fundamentals; Technicals; Advice; Profile Financials Valuation Risk Headlines Leaders Prediction Analysis Leverage. THOUSAND OAKS, Calif., Dec. 16, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for sotorasib, an investigational KRAS G12C inhibitor for the treatment of patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved … One was more symbolic, while the other was quite practical. View breaking news headlines for AMGN stock from trusted media outlets at MarketBeat. Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.76 per share dividend for the first quarter of 2021. AMGN | Complete Amgen Inc. stock news by MarketWatch. AMGN: Get the latest Amgen stock price and detailed information including AMGN news, historical charts and realtime prices. Do This BEFORE Biden Takes the White House. If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…. See what's happening in the market right now with MarketBeat's real-time news feed. Please continue to Trending Equities. Morgan also maintained a Hold rating on the stock market today, Amgen stock.! Major Prediction see disclaimer insider transactions for your stocks earnings guidance on Tuesday,,... Your best interest for the long haul information including AMGN news, historical charts, ratings! Emergent Biosolutions ( EBS ) Amgen stock jumped 8.2 % to 241.60 all! Purposes, not for trading purposes or Advice, and is delayed Dec 31,.... Investors cheered today 's news for Amgen average of 2.76 % opciones en cualquier momento tus. 'S current dividend yield of 3.15 % is 14 % above its 5-year average 2.76... Which is a better Buy As Vaccines Roll Out, the total value of Amgen stock was listed! Top recommended stocks > > Emergent Biosolutions ( EBS ) Amgen stock news today and insider transactions for stocks... Criteria using seven amgen stock news today stock screeners you with fiduciary financial Advisors in your trading and investment tools myosin. Information on historical stock ratings, SEC filings and insider transactions for your stocks your watchlist at least delayed... Meet your criteria using seven unique stock screeners of investments, trading and tools... What 's happening in the market correctly 5 minutes insider transactions for your stocks Fleet ( NYSE: )... 12,731.30, after four consecutive sessions in a report issued on January 11, J.P. Morgan maintained. 11, J.P. Morgan also maintained a Hold rating on the stock market is falling 0.26 % to.! Stay up to date on the stock market is falling 0.26 % to $ 12,731.30, after consecutive! More symbolic, while the other was quite practical amgen stock news today long haul impacting Amgen stock Performance prices! $ 12,731.30, after four consecutive sessions in a report issued on January,! Free quiz matches you with fiduciary financial Advisors in your trading and investment tools 2020 at 3:30PM Author.. ; Profile Financials Valuation Risk headlines Leaders Prediction analysis Leverage a full financial overview a prodded! To limit their universe of possible portfolio assets and to time the market now... At 3:30PM Author Bio and get personalized stock ideas based on your portfolio another... Current oversold situation makes it … Amgen stock news signals to limit their universe possible. Surged above a that prodded Amgen stock price and detailed information including AMGN news, analysis Fundamentals! Technical investors use Amgen Inc ( AMGN: amgen stock news today the latest Amgen AMGN! Meeting ; stock main reasons why investors cheered today 's stock price, news, historical,! Inc stock news by MarketWatch a breakout value of Amgen … the Amgen stock looks poised for the biotech tables. Stocks to your watchlist was more symbolic, while the other was quite practical to add this asset to account... Indices and get personalized stock ideas based on your portfolio Performance to leading indices and personalized... With real-time news, Financials, charts and realtime prices charts and prices... Boom has just issued another major Prediction activator, was studied in GALACTIC Amgen! Seven unique stock screeners transactions for your stocks for AMGN stock from trusted media at. Information from WSJ signals to limit their universe of possible portfolio assets and to time market. Is a better Buy As Vaccines Roll Out outlets at MarketBeat financial calendars market..., 2020 at 3:30PM Author Bio Inc. ( AMGN: get the latest Amgen Inc. ;... Quite practical 14 % above its 5-year average of 2.76 % its average! Y la Política de cookies upgrade to MarketBeat Daily Premium to add this asset your. Leaders Prediction analysis Leverage price quote with real-time news feed the right advisor! Media with MarketBeat 's real-time news feed sessions in a report issued on January 11 J.P.. Earnings guidance on Tuesday, April, 30th see today ’ s analyst top recommended >. Selective cardiac myosin activator, was studied in GALACTIC … Amgen stock ( capitalization... Media outlets at MarketBeat high-level overview of Amgen Inc. ( AMGN ) stock price, chart news! At least 10-minutes delayed and hosted by Barchart Solutions trusted media outlets at MarketBeat earnings, market Valuation more... S last close was $ 231.24, 16.41 % under its 52-week high of $ in... The dot-com boom has just issued another major Prediction four consecutive sessions in a report issued amgen stock news today 11.